Generate a tailored SOP for Dr. Dominic De Nardo. Improve your application with a focused, well-structured draft.
Dominic De Nardo leads the Innate Immune Signaling Group at the Department of Biochemistry & Molecular Biology within the Immunity Program of the Monash Biomedicine Discovery Institute. His research program aims to deepen the understanding of fundamental molecular mechanisms controlling innate immune responses, focusing on the cytosolic DNA sensing pathway, cGAS-STING. Dominic graduated with a PhD in 2009 from the University of Melbourne, Australia, where he developed a keen interest in the mechanisms of Toll-like receptor activation in macrophages. He subsequently accepted a postdoctoral position at the Institute of Innate Immunity in Bonn, Germany, where he identified the molecular mechanisms that enable high-density lipoprotein to reduce inflammation, results published in Nature Immunology. In 2014, he was awarded the Seymour Vivian Milstein Young Investigator Award for his notable contributions to basic research from the International Cytokine and Interferon Society. After returning to Melbourne in late 2014, he continued his research at the Walter Eliza Hall Institute of Medical Research before moving to Monash University in 2019. His research findings have been published in top-ranked journals including Nature Immunology, Cell Reports, Cell, Immunity, Nature Communications, and PNAS.
Monash University • Melbourne, Australia
Leading the Innate Immune Signaling Group and conducting research on innate immune responses.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.